Clinical TrialsSearch results
Number of results: 2568
Recruiting
- General Drug Use-Results Survey of COMLEX OTIC SOLUTION 1.5%
- Otitis externa, Chronic otitis media, and Acute otitis media
- CEOLIA Pharma.Co.Ltd Pharmacovigilance Office
- 2024-06-04
Not yet recruiting
- A Phase 3 Study to Evaluate MK-2870 in Advanced/Metastatic Gastroesophageal Adenocarcinoma
- Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma
- Koh Yasuhiro
- 2024-06-03
Not yet recruiting
- Beamion BCGC-1: A Phase Ib and Phase II trial of zongertinib in combination with intravenous trastuzumab deruxtecan (T-DXd) or in combination with intravenous trastuzumab emtansine (T-DM1) for treatment of patients with advanced HER2+ mBC and mGEAC
- Advanced HER2+ mBC and mGEAC
- Sila Aykut Yazgili
- 2024-06-03
Recruiting
- ADVISR trial
- overactive bladder (OAB) patients with residual OAB symptoms after receiving anticholinergic drugs
- Yoshida Soichiro
- 2024-06-03
Recruiting
- Translational research:CARTiEr study
- Ewing's sarcoma or solid tumors diagnosed as advanced relapsed with no standard treatment or refract
- Nakatsura Testuya
- 2024-06-03
Recruiting
- Validation of efficacy of online prolonged exposure for PTSD:a multicenter randomized controlled trial
- PTSD, Post Traumatic Stress Disorder
- Ino Keiko
- 2024-06-03
Not yet recruiting
- A Survey of Recombinant ADAMTS13 in Participants with Congenital Thrombotic Thrombocytopenic Purpura
- Thrombotic Thrombocytopenic Purpura
- Contact for Clinical Trial Information
- 2024-05-30
Not yet recruiting
- Clinical research to analyze gene expression and protein expression in tape stripping samples collected from cancer patients after the initiation of chemotherapy and healthy volunteers.
- Cancer
- Furihata Kenichi
- 2024-05-30
Recruiting
- Association between device-related parameters and adherence to CPAP
- Sleep apnea syndrome (SAS)
- Chin Kazuo
- 2024-05-30
Recruiting
- Relationship Between Frequency of Hipnotic Use and CPAP Adherence
- Sleep apnea syndrome (SAS)
- Chin Kazuo
- 2024-05-30